INT230-6
Intensity Therapeutics
['sarcoma']
happening now at #asco22, dr. matt ingham joins a panel of fellow sarcoma researchers to discuss his study of int230-6 across a broad spectrum of soft-tissue sarcomas. more info: 
Updates on innovations in #cancer research, prevention, care, and education from the Herbert Irving Comprehensive Cancer Center at @columbiamed/@nyphospital.